---
title: "PHARMALINK CONSULTING OPERATIONS LTD — Ownership Dossier"
canonical: https://whiteintel.dev/entity/44aaa153-b60c-5ff1-9364-ad54475df6e1
json: https://whiteintel.dev/api/public/dossier/44aaa153-b60c-5ff1-9364-ad54475df6e1
identifier: oo:GB-COH-NI611117
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# PHARMALINK CONSULTING OPERATIONS LTD

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `oo:GB-COH-NI611117`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/44aaa153-b60c-5ff1-9364-ad54475df6e1  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/44aaa153-b60c-5ff1-9364-ad54475df6e1  

## Ownership & control

### Owners / controllers

- **PHARMALINK CONSULTING LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/bf1439b2-4a99-5d56-9886-b65b03a84bce
- **Genpact Limited** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/d80404cc-51f4-4fcb-ae62-e5d5a5ca0dc5
- **PHARMALINK CONSULTING LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/bf1439b2-4a99-5d56-9886-b65b03a84bce

### UBO chain (walk to the ultimate owner)

A **5-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `NI611117`
- **Status:** active
- **Type:** ltd
- **Incorporated:** 2012-02-10
- **Registered office:** Floor 3 Adelaide Exchange, 24-26 Adelaide Street, Belfast, Northern Ireland, BT2 8GD
- **SIC:** 74909

### Officers

- BRIDGES, Stuart Mcgow — secretary · appointed 2023-03-24
- BRIDGES, Stuart Mcgow, Mr. — director · Scottish · appointed 2022-06-09
- D'SOUZA, Lester — director · British · appointed 2020-01-31
- BALL, Judith Mary Anne — director · British · appointed 2012-02-10 · resigned 2013-10-01
- BHATTACHARYA, Ishila — director · British · appointed 2021-06-07 · resigned 2022-04-30
- DAS, Orijit — director · British · appointed 2015-01-02 · resigned 2016-01-01
- GRIFFIN, Peter William — director · British · appointed 2012-02-10 · resigned 2015-01-31
- LOUGHREY, Una Mary — director · British · appointed 2013-11-19 · resigned 2014-05-29
- MAZHARI, Ahmed Jamil, Mr. — director · British · appointed 2015-01-02 · resigned 2020-01-31
- THOMAS, Sharon May — director · British · appointed 2016-01-01 · resigned 2021-04-02

### Beneficial owners (Persons with Significant Control)

- [Genpact Limited](https://whiteintel.dev/entity/d80404cc-51f4-4fcb-ae62-e5d5a5ca0dc5) — 75–100% shares · corporate PSC · Bermuda — since 2023-12-28
- [Pharmalink Consulting Limited](https://whiteintel.dev/entity/bf1439b2-4a99-5d56-9886-b65b03a84bce) — 75–100% shares · corporate PSC · England — ceased 2023-12-28

## Provenance

- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/NI611117
- companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/NI611117

## Get the full, resolved dossier (agent-callable)

The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent:

```bash
npx -y @whiteintel/mcp-server   # then: get_dossier · trace_ownership_path · check_offshore_exposure
```

Or unlock a one-off cited dossier for **PHARMALINK CONSULTING OPERATIONS LTD** — https://whiteintel.dev/entity/44aaa153-b60c-5ff1-9364-ad54475df6e1 · pricing https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **PHARMALINK CONSULTING OPERATIONS LTD**. Human view: https://whiteintel.dev/entity/44aaa153-b60c-5ff1-9364-ad54475df6e1 · Structured JSON: https://whiteintel.dev/api/public/dossier/44aaa153-b60c-5ff1-9364-ad54475df6e1._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._